Amer Asseri, Phd Email and Phone Number

Dr. Amer Asseri was born on the 5th of May 1981 in Mahayl, Saudia Arabia. After finishing secondary education, he started his study in biochemistry at the Faculty of Science at King Abdulaziz University in Jeddah and graduated in 2004 with a Bachelor's degree. After graduation, he worked as a medical lab technician in the Saudi German Hospital in Jeddah for two years. From 2007 until 2013, he worked as an academic technician at King Abdulaziz University. During that period, he obtained his master's degree (2011), in technical anatomy and histology. He has published two scientific books and other scientific papers in the field of histology and biochemistry. In 2013 he became a lecturer in the Biochemistry Department – Faculty of Science at King Abdulaziz University. In the period between 2016-2020, he started a Ph.D. journey on Medical Biochemistry at the Department of Molecular Cell Biology at Vrije Universiteit Amsterdam, under the supervision of Dr. Dirk Bald and Prof. Holger Lill. Asseri’s project at VU Amsterdam was embedded within the Amsterdam Institute of Molecular and Life Sciences (AIMMS), a research center that uniquely joins Molecular and Life Sciences and aims at the elucidation of molecular mechanisms of diseases and the development of novel therapeutics. There, his studies mainly focused on the biochemical characterization of bacterial membrane proteins and their role as novel drug targets. During his Ph.D., he was involved in a research collaboration with the Membrane Bioenergetics Group at Delft University of Technology (a top technology university in the Netherlands) headed by Dr. Duncan McMillan. After obtaining his Ph. D., Asseri returned to Saudi Arabia to start his career as an assistant professor and researcher at King Abdulaziz University,Faculty of Science, Biochemistry department.

Amer Asseri currently works at the Department of Structural Biology, Vrije Universiteit Amsterdam. Amer does research in medical biochemistry​. Their most recent publication is 'OxPhos antibiotics'.